Volume 11, Number 6—June 2005
Research
Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units
Simona Bratu*, Antonella Eramo†, Robert Kopec‡, Elizabeth Coughlin‡, Monica Ghitan‡, Robert Yost‡, Edward K. Chapnick‡, David Landman*
, and John Quale*
, and John Quale*Table 1
Clinical information for patients with methicillin-resistant Staphylococcus aureus infection during the outbreak period
| Patient | Age at onset | Sex | Strain | Infection type | Initial therapy | Definitive therapy |
|---|---|---|---|---|---|---|
| P1, newborn | 8 d | F | USA 400 | Preseptal cellulitis | Nafcillin, cefotaxime | Topical gentamicin |
| P2, newborn | 13 d | F | USA 400 | Omphalitis, otitis externa | Ampicillin, cefotaxime | Topical mupirocin |
| P3, mother | 33 y | F | USA 400 | Breast abscess | Cefazolin | Surgical drainage, vancomycin, topical mupirocin |
| P4, newborn | 2 d | M | USA 400 | Omphalitis, pustulosis | Nafcillin Gentamicin | Gentamicin, topical mupirocin |
| P5, newborn | 4 d | M | USA 400 | Pustulosis | Cephalexin | Topical bacitracin |
| P6, newborn | 2 d | M | USA 400 | Pustulosis | None | Local wound care |
| P7, newborn | 1 d | F | USA 400 | Pustulosis, mastitis | Topical mupirocin | Vancomycin |
| P8, mother | 24 y | F | Unique | Peripheral IV catheter site | Cefazolin | Trimethoprim-sulfamethoxazole, catheter removal |
